Jiangsu Hengrui Medicine Co., Ltd.

This large, late-stage study is comparing a new two-drug combination (camrelizumab and famitinib) against standard platinum-based chemotherapy for women with recurrent or metastatic cervical cancer. The main goals are to see if the new combination helps patients live longer witho…

This study is testing whether a new drug called SHR-3167 works as well as or better than a standard long-acting insulin (degludec) for controlling blood sugar in people with type 2 diabetes. It involves 173 adults who are already using insulin with or without other diabetes pills…

This large study is testing whether adding a new drug called HR070803 to standard chemotherapy works better for people with advanced colorectal cancer that has spread and cannot be removed by surgery. About 669 patients will receive either the new combination or the current stand…

This is an early-stage study to test the safety and find the right dose of a new drug called HRS-6209 for people with advanced solid tumors. It will involve 56 patients whose cancer has progressed despite standard treatments. The main goals are to see how much of the drug the bod…

This large Phase 3 trial is testing whether a new drug called SHR-A1811, given with or without another medication, works better than the current standard treatment for advanced HER2-positive breast cancer that has returned or spread. The study will enroll 868 women to compare how…

This study is testing whether a combination of two drugs, camrelizumab and rivoceranib, can help prevent liver cancer from returning in patients who are at high risk of recurrence after their initial tumor has been surgically removed or destroyed. The trial will compare the drug …

This study is testing a new topical cream called SHR0302Base to see if it can safely help restore skin color in people with nonsegmental vitiligo. About 155 participants will be randomly assigned to receive either the active cream or an inactive version to compare results. The ma…

This is a first-in-human study to test the safety and side effects of a new drug called HRS-4642. It is for adults with advanced solid tumors that have a specific genetic change called a KRAS G12D mutation. The main goals are to find a safe dose and see how the body processes the…

This study is for people with liver cancer that cannot be surgically removed. It is testing if adding two newer drugs (an immunotherapy and a targeted therapy) to the standard artery-blocking treatment (TACE) works better than the standard treatment alone. The main goal is to see…

This study is testing the safety and effectiveness of a new drug called HRS-4642 when given with other cancer medications. It is for adults with advanced solid tumors that have a specific genetic change called KRAS G12D. The goal is to see if this combination can help control the…

This study is testing whether a new medication called SHR-3167 works as well as standard insulin injections for controlling blood sugar in people with type 2 diabetes. Researchers will compare both treatments in 275 adults who are already taking metformin but still need better bl…